Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

Jellyfish stings, particularly from cubozoans, pose a significant threat to human health worldwide. However, the major toxins responsible for the clinical symptoms following envenomation by box jellyfish (class Cubozoa) are not well understood. In this study, we investigated the major toxic components of Carybdea brevipedalia venom (CbV) as a representative model of box jellyfish venoms. We identified the key lethal toxin components (CbVLT) from crude CbV. For this, we isolated the toxic components using anion exchange chromatography and fast protein liquid chromatography (FPLC) methods, accompanied by toxicity evaluations. In vitro toxicity assays confirmed the strong cytotoxicity and hemolytic activity of CbVLT. Furthermore, CbVLT exhibited strong lethality in zebrafish, inducing notable hemorrhage and swelling, significant lactate dehydrogenase (LDH) activity, and fatal histopathological changes in vital organs (brain, gills, and heart). These results indicated that CbVLT contains the key lethal toxins in the venom. Subsequently, LC-MS/MS analysis identified 8 toxin homologs in CbVLT, including potassium channel toxins, cytolysins, hemolysins, proteases, and hydrolases. These toxins are responsible for the severe local and systemic reactions and even death caused by C. brevipedalia stings. These findings uncover and characterize the key lethal toxins in CbV, which will help reveal the molecular mechanisms of the venom's lethality and significantly aid in developing therapeutic strategies to treat stings from the cubozoa jellyfish in the future.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00204-025-04117-wDOI Listing

Publication Analysis

Top Keywords

toxic components
12
box jellyfish
12
key lethal
12
components carybdea
8
carybdea brevipedalia
8
brevipedalia venom
8
toxins responsible
8
lethal toxins
8
jellyfish
5
toxins
5

Similar Publications

Proteomic characterization and lethality of the venom of the Black Judean scorpion, Hottentotta judaicus (Buthidae): expanded toxin diversity and revisited toxicological significance.

Arch Toxicol

September 2025

Laboratorio de Proteómica, Facultad de Microbiología, Instituto Clodomiro Picado, Universidad de Costa Rica, San José, 11501, Costa Rica.

The scorpion Hottentotta judaicus inhabits the Levant region of the Middle East, including Lebanon, Jordan, Palestine, and Israel. While previous research focused on its insecticidal properties and sodium-channel-targeting toxins, its venom remains largely unexplored using modern proteomic approaches. We analyzed the venom composition of H.

View Article and Find Full Text PDF

Isatin (1-indole-2,3-dione) is a privileged nitrogen-containing heterocyclic framework that has received considerable attention in anticancer drug discovery owing to its general biological behavior and structural diversity. This review focuses on isatin-heterocyclic hybrids as a valuable model in the development of new anti-cancer drugs that may reduce side effects and help overcome drug resistance, discussing their synthetic approaches and mechanism of action as apoptosis induction through kinase inhibition. With various chemical modifications, isatin had an excellent ability to build powerful isatin hybrids and conjugates targeting multiple oncogenic pathways.

View Article and Find Full Text PDF

The intramembrane aspartic protease, γ-secretase, is a heterotetrameric protein complex composed of four integral membrane proteins: presenilin (PSEN), nicastrin (NCT), Anterior pharynx defective-1 (APH-1), and presenilin enhancer 2 (PEN-2). These components are sequentially assembled into a functional complex. γ-secretase is ubiquitously expressed in all cells and tissues and exhibits enzymatic activity akin to "molecular scissors" by cleaving various type I transmembrane proteins.

View Article and Find Full Text PDF

Senescence Under the Lens: X-ray vs. Proton Irradiation at Conventional and Ultra-High Dose Rate.

Radiat Res

September 2025

Unité de Recherche en Biologie Cellulaire (URBC), Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.

Conventional radiotherapy based on X rays is used to treat more than 50% of cancers. Although effective, radiotherapy can damage healthy tissues around the tumor due to the X-ray dose deposition profile, as well as the safety margin needed to compensate for dose uncertainties. A notable side effect is cellular senescence, characterized by the cessation of cell division while maintaining metabolic activity and promoting the secretion of various components, called the senescence-associated secretory phenotype.

View Article and Find Full Text PDF

Ferroptosis-Enhanced Radiopharmaceutical Therapy via a Manganese-Based Nanoplatform.

Mol Pharm

September 2025

Department of Nuclear Medicine, Sichuan Provincial People's Hospital, School of Medicine, University of Electronic Science and Technology of China, Chengdu 610072, China.

Radiopharmaceutical therapy (RPT) is a therapeutic strategy that delivers radionuclides in a targeted manner to achieve precise radiation-induced killing of tumor cells. While RPT primarily induces tumor cell death through apoptosis, resistance to apoptosis has been identified as a key mechanism underlying the radioresistance. Therefore, integrating nonapoptotic cell death pathways with RPT offers a promising strategy to enhance its therapeutic efficacy.

View Article and Find Full Text PDF